🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare treatment with olorofim versus trea...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-03-31
Trial ID
NCT05101187
Double blind, placebo controlled, parallel group ascending dose study evalu...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2015-02
Trial ID
NCT02342574
Open label evaluation of a single intravenous dose of F901318 to healthy ma...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05
Trial ID
NCT03076905
Treatments Being Tested
A Phase I, open label study evaluating safety, tolerability and pharmacokin...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-12-12
Trial ID
NCT03340597
Treatments Being Tested
Non-randomized, multi-centre, open label, uncontrolled, multiple dose, phas...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-03
Trial ID
NCT03036046
Treatments Being Tested
Double blind, placebo controlled, ascending single oral dose, sequential gr...
Status
Completed
Location
Simbec Orion
Start Date
2015-10
Trial ID
NCT02394483
This study assesses the pharmacokinetics and safety of the new antifungal F...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-04-20
Trial ID
NCT02856178
Treatments Being Tested
This is a Phase I, single-centre, randomised, open-label, crossover study i...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2019-12-05
Trial ID
NCT04207957
Treatments Being Tested
F901318 is a potent new antifungal agent for the treatment of systemic fung...
Status
Completed
Location
Simbec Research
Start Date
2014-08
Trial ID
NCT02142153
Double blind, placebo controlled, ascending multiple (10) oral dose, sequen...
Status
Completed
Location
Simbec Research Ltd
Start Date
2016-05
Trial ID
NCT02737371